HKD 55.1
(-1.08%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 3.24 CNY | 3.81% |
2022 | 3.15 CNY | 80.0% |
2021 | 1.75 CNY | 65.09% |
2020 | 1.06 CNY | 55.88% |
2019 | 0.68 CNY | -28.42% |
2018 | 0.95 CNY | 69.64% |
2017 | 0.56 CNY | 21.74% |
2016 | 0.46 CNY | 170.59% |
2015 | 0.17 CNY | -22.73% |
2014 | 0.22 CNY | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q3 | 0.86 CNY | 0.0% |
2024 Q1 | 0.67 CNY | 28.85% |
2024 Q2 | 0.79 CNY | 17.91% |
2023 Q1 | 0.74 CNY | 51.02% |
2023 Q3 | 0.94 CNY | -12.15% |
2023 Q4 | 0.52 CNY | -44.68% |
2023 FY | - CNY | 3.81% |
2023 Q2 | 1.07 CNY | 44.59% |
2022 Q3 | 0.93 CNY | -4.12% |
2022 FY | - CNY | 80.0% |
2022 Q4 | 0.49 CNY | -47.31% |
2022 Q2 | 0.97 CNY | 83.02% |
2022 Q1 | 0.53 CNY | 0.0% |
2021 Q3 | 0.31 CNY | -22.5% |
2021 FY | - CNY | 65.09% |
2021 Q4 | 0.53 CNY | 70.97% |
2021 Q2 | 0.40 CNY | -23.08% |
2021 Q1 | 0.52 CNY | 147.62% |
2020 Q4 | 0.21 CNY | -8.7% |
2020 Q3 | 0.23 CNY | -56.6% |
2020 Q1 | 0.11 CNY | 240.56% |
2020 Q2 | 0.53 CNY | 381.82% |
2020 FY | - CNY | 55.88% |
2019 Q3 | 0.26 CNY | 8.33% |
2019 FY | - CNY | -28.42% |
2019 Q4 | 0.03 CNY | -87.58% |
2019 Q2 | 0.24 CNY | 71.43% |
2019 Q1 | 0.14 CNY | 0.0% |
2018 Q4 | 0.14 CNY | -48.15% |
2018 FY | - CNY | 69.64% |
2018 Q2 | 0.75 CNY | 476.92% |
2018 Q1 | 0.13 CNY | 75.68% |
2018 Q3 | 0.27 CNY | -64.0% |
2017 Q2 | 0.18 CNY | 20.0% |
2017 Q1 | 0.15 CNY | 0.0% |
2017 FY | - CNY | 21.74% |
2017 Q4 | 0.07 CNY | -47.14% |
2017 Q3 | 0.14 CNY | -22.22% |
2016 FY | - CNY | 170.59% |
2015 FY | - CNY | -22.73% |
2014 FY | - CNY | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Life Healthcare Group Limited | 0.01 HKD | -33650.0% |
China Biotech Services Holdings Limited | -0.10 HKD | 3369.425% |